| Literature DB >> 33271569 |
Hutan Ashrafian1, Viknesh Sounderajah1, Robert Glen1,2, Timothy Ebbels1, Benjamin J Blaise1, Dipak Kalra3, Kim Kultima4, Ola Spjuth5, Leonardo Tenori6, Reza M Salek7, Namrata Kale7, Kenneth Haug7, Daniel Schober8, Philippe Rocca-Serra9, Claire O'Donovan7, Christoph Steinbeck10, Isaac Cano11, Pedro de Atauri12, Marta Cascante12.
Abstract
Metabolomics encompasses the systematic identification and quantification of all metabolic products in the human body. This field could provide clinicians with novel sets of diagnostic biomarkers for disease states in addition to quantifying treatment response to medications at an individualized level. This literature review aims to highlight the technology underpinning metabolic profiling, identify potential applications of metabolomics in clinical practice, and discuss the translational challenges that the field faces. We searched PubMed, MEDLINE, and EMBASE for primary and secondary research articles regarding clinical applications of metabolomics. Metabolic profiling can be performed using mass spectrometry and nuclear magnetic resonance-based techniques using a variety of biological samples. This is carried out in vivo or in vitro following careful sample collection, preparation, and analysis. The potential clinical applications constitute disruptive innovations in their respective specialities, particularly oncology and metabolic medicine. Outstanding issues currently preventing widespread clinical use are scalability of data interpretation, standardization of sample handling practice, and e-infrastructure. Routine utilization of metabolomics at a patient and population level will constitute an integral part of future healthcare provision.Entities:
Keywords: Metabolomics; Personalised medicine; Precision medicine
Mesh:
Year: 2020 PMID: 33271569 PMCID: PMC8436726 DOI: 10.1159/000513545
Source DB: PubMed Journal: Med Princ Pract ISSN: 1011-7571 Impact factor: 2.132